BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34715828)

  • 1. Evolution of a refractory prolactin-secreting pituitary adenoma into a pituitary carcinoma: report of a challenging case and literature review.
    Dai C; Sun B; Guan S; Wang W; Liu H; Li Y; Zhang J; Kang J
    BMC Endocr Disord; 2021 Oct; 21(1):217. PubMed ID: 34715828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.
    Dai C; Liang S; Sun B; Kang J
    Front Endocrinol (Lausanne); 2020; 11():608422. PubMed ID: 33362722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas.
    Shimon I; Sosa E; Mendoza V; Greenman Y; Tirosh A; Espinosa E; Popovic V; Glezer A; Bronstein MD; Mercado M
    Pituitary; 2016 Aug; 19(4):429-36. PubMed ID: 27138902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature.
    Lizzul L; Lombardi G; Barbot M; Ceccato F; Gardiman MP; Regazzo D; Bellu L; Mazza E; Losa M; Scaroni C
    Pituitary; 2020 Aug; 23(4):359-366. PubMed ID: 32232709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin-Secreting Pituitary Carcinoma with Dural Metastasis: Diagnosis, Treatment, and Future Directions.
    Seltzer J; Carmichael JD; Commins D; Liu CS; Omura E; Chang E; Zada G
    World Neurosurg; 2016 Jul; 91():676.e23-8. PubMed ID: 27157283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary carcinoma - case series and review of the literature.
    Du Four S; Van Der Veken J; Duerinck J; Vermeulen E; Andreescu CE; Bruneau M; Neyns B; Velthoven V; Velkeniers B
    Front Endocrinol (Lausanne); 2022; 13():968692. PubMed ID: 36157469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin-secreting carcinoma of the pituitary: clinicopathological and immunohistochemical study of a case with intracranial and intraspinal dissemination.
    Bayindir C; Balak N; Gazioğlu N
    Br J Neurosurg; 1997 Aug; 11(4):350-5. PubMed ID: 9337937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary carcinoma with intraspinal metastasis: report of two cases and review of the literature.
    Wang YQ; Fan T; Zhao XG; Liang C; Qi XL; Li JY
    Int J Clin Exp Pathol; 2015; 8(8):9712-7. PubMed ID: 26464743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatments of multi-invasive giant prolactinoma.
    Yang MY; Shen CC; Ho WL
    J Clin Neurosci; 2004 Jan; 11(1):70-5. PubMed ID: 14642373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin-secreting macroadenoma in a prepubertal girl.
    Kashiwagi S; Nishizaki T; Harada K; Ito H; Setoguchi M; Takahashi M; Ishihara T
    Childs Nerv Syst; 1998 Oct; 14(10):602-5. PubMed ID: 9840387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term response of pituitary carcinoma to temozolomide. Report of two cases.
    Fadul CE; Kominsky AL; Meyer LP; Kingman LS; Kinlaw WB; Rhodes CH; Eskey CJ; Simmons NE
    J Neurosurg; 2006 Oct; 105(4):621-6. PubMed ID: 17044568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications for surgical treatment of prolactin-secreting pituitary adenomas].
    Kalinin PL; Astaf'eva LI; Kadashev BA; Ismailov DB
    Zh Vopr Neirokhir Im N N Burdenko; 2017; 81(5):117-124. PubMed ID: 29076475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single- center experience of prolactin-producing pituitary adenomas without hyperprolactinemia: Its incidence and clinical management.
    Ogawa Y; Tominaga T
    Clin Neurol Neurosurg; 2020 Nov; 198():106123. PubMed ID: 32818756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant prolactinoma: case report and review of the literature.
    Popadić A; Witzmann A; Buchfelder M; Eiter H; Komminoth P
    Surg Neurol; 1999 Jan; 51(1):47-54; discussion 54-5. PubMed ID: 9952123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of prolactin-secreting pituitary adenomas.
    Neal JH; Weiss MH
    West J Med; 1990 Nov; 153(5):546-7. PubMed ID: 2260295
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
    Taweesomboonyat C; Oearsakul T
    World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin secreting pituitary carcinoma.
    Petterson T; MacFarlane IA; MacKenzie JM; Shaw MD
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1205-6. PubMed ID: 1479402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenocorticotropic hormone-producing pituitary carcinoma with intracranial metastases.
    Shastri BR; Nanda A; Fowler M; Levine SN
    World Neurosurg; 2013 Feb; 79(2):404.e11-6. PubMed ID: 22079280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temozolomide retreatment in a recurrent prolactin-secreting pituitary adenoma: Hormonal and radiographic response.
    Strowd RE; Salvatori R; Laterra JJ
    J Oncol Pharm Pract; 2016 Jun; 22(3):517-22. PubMed ID: 25616657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: long term follow-up.
    Feigenbaum SL; Downey DE; Wilson CB; Jaffe RB
    J Clin Endocrinol Metab; 1996 May; 81(5):1711-9. PubMed ID: 8626821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.